About Pendulum Therapeutics
Pendulum Therapeutics is an evidence-based biotechnology company that applies high-resolution DNA sequencing to develop and commercialize microbiome interventions targeting specific diseases. Its flagship product, Pendulum Glucose Control, is a clinically validated medical probiotic shown to help manage A1C and blood sugar levels in people with type 2 diabetes. The company serves consumers and healthcare providers seeking science-backed, microbiome-based solutions for metabolic and chronic health conditions.
Company details
Funding
Total raised
$121M
Last stage
Growth
Investors
Founders
James Bullard
Colleen Cutcliffe
PhD in Biochemistry and Molecular Biology from Johns Hopkins University; 25+ years leading biology teams in academia, pharma, and biotech; formerly Senior Manager of Biology at Pacific Biosciences.
LinkedInJohn Eid
Co-founder and Chief Science Officer at Pendulum Therapeutics; met co-founders at Pacific Biosciences.
LinkedInJim Bullard
Co-founder of Pendulum Therapeutics (formerly Whole Biome); scientist background in microbiology and biochemistry.
What happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.